HCS Pharma is a biotech company focused on preclinical in vitro studies, specialized in high content analysis (HCA) and high content screening (HCS). We evaluate the efficacy and safety of your molecules (drug, ingredient, or cosmetic actives) on innovative 2D and 3D cellular models. HCS Pharma owns and sells BIOMIMESYS® technology, a reproducible and physiological surrogate extracellular matrix for 3D cell culture.
November 29th & 30th, 2022
December 7th & 8th, 2022